| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Viking Therapeutics (NASDAQ:VKTX) has outperformed the market over the past 5 years by 39.42% on an annualized basis producing an average annual return of 53.7%. Currently, Viking Therapeutics has a market capitalization of $6.35 billion.
Buying $100 In VKTX: If an investor had bought $100 of VKTX stock 5 years ago, it would be worth $817.40 today based on a price of $57.30 for VKTX at the time of writing.
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: VKTX
